COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Rheumatology"
DOI: 10.1007/s10067-022-06157-4
Abstract: Patients with giant cell arteritis (GCA) represent a fragile population with an increased infection risk. In a recent study, older age, a higher number of comorbidities, higher disease activity and prednisolone ≥ 10 mg/day were associated with… read more here.
Keywords: gca; cell arteritis; giant cell; patients giant ... See more keywords
Circulating interleukin‐6 as a biomarker in a randomized controlled trial of modified‐release prednisone vs immediate‐release prednisolone, in newly diagnosed patients with giant cell arteritis
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Rheumatic Diseases"
DOI: 10.1111/1756-185x.13702
Abstract: To measure serial interleukin (IL)‐6 levels in newly diagnosed patients with giant cell arteritis (GCA), treated in a randomized controlled trial of modified‐release prednisone (MR) vs immediate‐release prednisolone (IR) used in a tapering regimen conforming… read more here.
Keywords: cell arteritis; giant cell; patients giant; diagnosed patients ... See more keywords
OP0240 Favourable longterm outcome in patients with giant cell arteritis treated with tocilizumab. real life data from a swiss centre
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.6585
Abstract: Background Tocilizumab (TCZ) has been shown to be effective for achieving sustained glucocorticoid (GC)-free remission in patients with giant cell arteritis (GCA) 1,2. However, data on real life patients and longterm follow up is still… read more here.
Keywords: giant cell; treatment; tcz; remission ... See more keywords
Prevalence and impact of cerebrovascular risk factors in patients with giant cell arteritis: An observational study from the Spanish national registry.
Sign Up to like & getrecommendations! Published in 2022 at "Medicina clinica"
DOI: 10.21203/rs.3.rs-1260295/v1
Abstract: OBJECTIVE To assess the prevalence and impact of cerebrovascular risk factors (CRF) on cerebrovascular events (CVE) in patients with giant cell arteritis (GCA). METHODS Analysis of the patients diagnosed with GCA identified in the Spanish… read more here.
Keywords: cerebrovascular risk; prevalence impact; impact cerebrovascular; risk factors ... See more keywords